Search Blog
November 2013
« Oct   Dec »


Amarantus BioScience CSO Publishes New Blog Entitled “The Golden Goose: Preparing PhenoGuard to Lay the Next Golden Egg”


By Market Exclusive

Amarantus BioScience, Inc. (OTCQB:
AMBS) published a new blog post on The Chairman’s Blog, written by
the company’s CSO, Dr. John Commissiong. is an
exclusive online media publication that enables key executive
officers a unique platform to share insights about their company and
industry trends.

CSO, Dr. John Commissiong, writes about the discovery of MANF and the
company’s plan to use its PhenoGuard Protein Discovery Engine
platform in the discovery of a new neurotrophic factor family.
Read his full blog post on

About Amarantus BioScience, Inc.

AmarantusBioScience, Inc. is a
development-stage biotechnology company founded in January 2008. The
Company has a focus on developing certain biologics surrounding the
intellectual property and proprietary technologies it owns to treat
and/or diagnose Parkinson’s disease, Traumatic Brain Injury and
other human diseases. The Company owns the intellectual property
rights to a therapeutic protein known as
Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and
is developing MANF-based products as treatments for brain disorders.
The Company also is a Founding Member of the Coalition for Concussion
Treatment (#C4CT), a movement initiated in collaboration with Brewer
Sports International seeking to raise awareness of new treatments in
development for concussions and nervous-system disorders. For further
information, please visit

About is
an exclusive, online media publication where publically and
privatively held firms alike share insights about their companies and
industries. enables upper tier management to
discuss issues that are of importance to their stakeholders,
shareholders, and interested parties in an informal environment. In
addition to management’s insightful blog posts,
staff and aggregate partners contribute articles on finance,
technology, health, and energy while providing updated market trends,
news, and information.